Ministry supports bolstering pharmaceutical cooperation with Japan
These seven sectors have been chosen because they can contribute 70 percent of the total Gross Domestic Product (GDP) for manufacturing, 65 percent of manufacturing exports, and 60 percent of industrial workers
Jakarta (ANTARA) – The Industry Ministry supports the strengthening of cooperation in pharmaceutical and medical device industries between Indonesia and Japan since the two industries are among the seven prioritized sectors in the Making Indonesia 4.0 roadmap.
The seven prioritized sectors are food and beverage, automotive, chemical, textile and textile products, electronic, pharmaceutical, and medical device industries.
“These seven sectors have been chosen because they can contribute 70 percent of the total Gross Domestic Product (GDP) for manufacturing, 65 percent of manufacturing exports, and 60 percent of industrial workers,” the ministry’s Acting Director General of the Chemical, Pharmaceutical, and Textile Industries (IKFT) Ignatius Warsito said at a business forum in Osaka, Japan, on Saturday, as stated in a written statement on Sunday.
Related news: Ministry supplies 10 drug molecules to boost domestic production
According to him, the Industry Ministry is deepening the industrial structure, increasing investment, and carrying out the Making Indonesia 4.0 roadmap initiative.
For that reason, the ministry will continuously support activities aimed at establishing comprehensive cooperation, including the implementation of the Indonesia-Japan Pharmaceutical and Medical Device Business Forum, which took place on October 5-7, 2022, in Osaka.
“This business forum, which was opened by the Indonesian Ambassador in Tokyo, focuses on bringing together pharmaceutical and medical device industry business players from Indonesia and business players/investors from Japan,” Chairman of the Indonesia-Japan Bilateral Committee of the Indonesian Chamber of Commerce and Industry (Kadin) Emmanuel L Wanandi said.
The business forum was attended by 15 business representatives from Indonesia, including nine pharmaceutical and medical device companies, as well as representatives from the Indonesian Pharmaceutical Companies Association (GPFI) and the Indonesian Medical Device Producers Association (ASPAKI).
Related news: Encouraging independence of Indonesian pharmaceutical industry
Head of the National Agency of Drug and Food Control (BPOM) Penny K. Lukito, while virtually delivering her remarks, invited pharmaceutical industry players in Japan to expand collaborations with Indonesia through technology-based research and development of medicines.
Meanwhile, the Secretary General of the Ministry of Health, Kunta Wibawa, in Osaka, highlighted the importance of transformation in the health sector, including primary service and hospital transformations, as well as building a resilient health system.
The business forum resulted in a signing of cooperation between GPFI and a Japanese partner, the Federation of Pharmaceutical Manufacturers Association of Japan (FPMAJ), in particular, to open up opportunities for collaboration in research and development as well as co-production.
Related news: Domestic pharmaceutical industry as a global health power: Minister
Related news: Pharmaceutical industry must use research for business development
No Byline Policy
Editorial Guidelines
Corrections Policy
Source